Author:
Quillinan N P,McIntosh D,Vernes J,Haq S,Denton C P
Subject
General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology
Reference21 articles.
1. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model;Shand;Arthritis Rheum,2007
2. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;LeRoy;J Rheumatol,1988
3. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study;Nihtyanova;QJM,2010
4. Therapeutic targets in systemic sclerosis;Denton;Arthritis Res Ther,2007
5. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease;Postlethwaite;Arthritis Rheum,2008
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献